MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.
about
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitisMonocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp miceCentrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse modelBerberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.Cerebellar Dysfunction in Multiple Sclerosis.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple SclerosisAccumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.Novel therapeutic approach by nicotine in experimental model of multiple sclerosis.Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.The role of chromogranin B in an animal model of multiple sclerosis.Purkinje cell loss in experimental autoimmune encephalomyelitis.Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.Immune characteristics study of AG490, a signal pathway inhibitor, in EAE model miceThe development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.Role of inactivated influenza vaccine in regulation of autoimmune processes in experimental autoimmune encephalomyelitis.Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.The enteric nervous system is a potential autoimmune target in multiple sclerosis.Microsomal Prostaglandin E Synthase-1 Facilitates an Intercellular Interaction between CD4⁺ T Cells through IL-1β Autocrine Function in Experimental Autoimmune Encephalomyelitis.Therapeutic effects of walnut oil on the animal model of multiple sclerosis.Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse ModelAnti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
P2860
Q28394597-E00E8B72-B784-4498-A7B4-EC0722CF050AQ30840308-CA7F60CB-09EB-4D44-B3A6-EF29EDA18580Q33682239-79813652-3E84-4853-9078-64C2FD499535Q33728244-B14CC264-413B-4138-BB24-899693F050F9Q33843083-EA8C20FC-9537-468B-80D0-B800958EAD68Q33911142-260AEDB5-AB96-4B3E-B967-AE97D816938CQ34146191-488878D9-5B86-4480-A631-1A1CD2054A9CQ34192160-F20D9F21-D020-4380-88DC-3FFADB05B280Q35145298-C716E81F-C30D-44A6-85A3-A488F599D100Q35800253-73EB1D4E-E4EE-4A0F-A598-350029675369Q35867011-22AD25B8-8BC7-4A87-A6CC-F0A8DCB9AEF3Q36750834-18D4C9F3-C7A2-4A8C-9C08-B6947C706947Q36859084-5D7A3832-D1F3-4C98-8094-8AFF7C6FF9CDQ36990042-5D577B0D-5666-4041-8BBC-24F56E769649Q37216886-A851FB87-2078-4023-8F24-445D071FE7B8Q37368941-353F93CA-176C-4581-B8D9-9E0E93D8D605Q37388654-49B78954-3E7E-43BF-8D99-37045DB7045AQ37610907-BEC34752-5C43-4710-A653-96F31F611962Q38059361-0EA6EB93-33ED-4C23-831E-33CEBF153C7AQ40466907-897C02A7-9C26-49E1-9786-29B1513E5DC5Q43736164-AA922CD6-B157-4F53-80D1-1E3F476082A7Q43887998-95BB1373-4526-4C53-A553-EA55F0FD2481Q44565890-A6067742-360B-4B5E-A65F-05A226399DCDQ46816215-4484E3B9-B952-42EE-8E80-DD0ECC234208Q47912566-042AFBB6-64BD-473B-9E21-D873B09C2EFBQ48013469-8674DB33-F982-422C-B17E-68E8BA492D60Q48094913-043C8739-07A1-493C-B4F9-1BD18B515DC7Q48096032-F3547200-97B9-43A9-A04C-6721801B05F1Q48792301-D8EDC3F2-0300-4E4A-930A-C149E208C8DEQ49543789-7D69F112-0593-410E-AB7F-0D4BA13AC3B4Q56889385-38ED263D-DD4C-4247-B4BF-2C601DFFD26BQ58122911-901F0D19-E057-4610-8942-7FDAD9FD3396Q58788563-88A36E10-BE2C-40B9-B745-F6AE1A8547AE
P2860
MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@ast
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@en
type
label
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@ast
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@en
prefLabel
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@ast
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@en
P2093
P2860
P1476
MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.
@en
P2093
Dilyana A Kostova-Bales
Doychin N Angelov
Justine T Tigno
Lukas P Frenzel
Magdalena Tary-Lehmann
Paul V Lehmann
Stefanie Kuerten
P2860
P356
10.1016/J.JNEUROIM.2007.06.016
P577
2007-07-25T00:00:00Z